Gianni Maggipinto - Publications

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.

Journal: Frontiers in immunology

Published: December 08, 2025

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

Journal: Frontiers in genetics

Published: May 21, 2024

Is 'ABO-D' really a ready-made package? Why these parameters should be analysed separately in correlation studies?

Journal: British journal of haematology

Published: March 20, 2022

Infusion of Allogeneic Mesenchymal Stromal Cells After Liver Transplantation: A 5-Year Follow-Up.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: July 09, 2021

COVID-19 and ABO blood group: another viewpoint.

Journal: British journal of haematology

Published: May 27, 2020

Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.

Journal: Kidney international

Published: March 07, 2018

A KEL*02mod allele responsible for an apparent maternity exclusion

Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Published: June 13, 2012

Poly(2-dimethylamino ethylmethacrylate)-based polymers to camouflage red blood cell antigens.

Journal: Biomacromolecules

Published: March 16, 2012